EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy

Wencheng Fu, Geng Wu iD

Molecules · 2023

DOI: 10.3390/molecules28073157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Wencheng Fu und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, the Joint International Research Laboratory of Metabolic & Dev…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The balance between anabolism and catabolism is disrupted with aging, with the rate of anabolism being faster than that of catabolism. Therefore, mTOR, whose major function is to enhance anabolism and inhibit catabolism, has become a potential target of inhibition for anti-aging therapy. Interestingly, it was found that the downregulation of the mTOR signaling pathway had a lifespan-extending effect resembling calorie restriction. In addition, the mTOR signaling pathway promotes cell proliferation and has been regarded as a potential anti-cancer target. Rapamycin and rapalogs, such as everolimus, have proven to be effective in preventing certain tumor growth. Here, we reviewed the basic knowledge of mTOR signaling, including both mTORC1 and mTORC2. Then, for anti-aging, we cited a lot of evidence to discuss the role of targeting mTOR and its anti-aging mechanism. For cancer therapy, we also discussed the role of mTOR signaling in different types of cancers, including idiopathic pulmonary fibrosis, tumor immunity, etc. In short, we discussed the research progress and both the advantages and disadvantages of targeting mTOR in anti-aging and anti-cancer therapy. Hopefully, this review may promote more ideas to be generated for developing inhibitors of mTOR signaling to fight cancer and extend lifespan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesNeoplasmsHumansAgingSignal TransductionMechanistic Target of Rapamycin Complex 1Cell Proliferation

Stichwörter der Autor:innen

aginganti-aginganti-cancer therapycancermTORmTOR inhibitionsenescence

Substanzen

TOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1MTOR protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, the Joint International Research Laboratory of Metabolic & Developmental Sciences MOE, Shanghai Jiao Tong University, Shanghai 20024…

ORCID-Profile: Geng Wu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key R&D Program of China

Zitieren

APA

Fu, W., & Wu, G. (2023). Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. Molecules. https://doi.org/10.3390/molecules28073157

Vancouver

Fu W, Wu G. Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. Molecules. 2023. doi:10.3390/molecules28073157

BibTeX
@article{Fu2023,
  author = {Fu, Wencheng and Wu, Geng},
  title = {Targeting mTOR for Anti-Aging and Anti-Cancer Therapy},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28073157}
}
Kostenlos starten →